Author: Scott Thomaston, AVP, EHSO The commissioning of the Health Sciences Research Building Phase 2 (HSRB2) brings a significant increase in Biosafety Level 3 (BSL3) and Animal Biosafety Level 3 (ABSL3) capacity to our research community. This addition of 12 high containment labs significantly adds to our ability to work with infectious biological agents that […]
New from NIH- FDA-NIH Want Your Input on a New Resource for Terminology in Clinical Research May 7, 2024To avoid the pitfalls that inconsistent use of terms can lead to, NIH and FDA developed a glossary of terms related to clinical research that could be used to assist the research community in effectively communicating about clinical trials. NIH and FDA are most interested in hearing community feedback on the utility of the glossary […]Lyric Jorgenson
- FDA-NIH Want Your Input on a New Resource for Terminology in Clinical Research May 7, 2024
- News from the Office of Technology Transfer